-
Posted by
Two Blokes Jul 1 -
Filed in
Stock
-
4 views
Tempus AI offers a compelling vision in precision oncology, boasting strong data assets, strategic partnerships, and rapid revenue growth. Valuation is rich, and execution risk is high—success depends on converting AI promise into validated, reimbursed diagnostics and sustainable cash flow. Tempus is a high-risk, high-reward play; I rate it a Hold, suitable only for speculative investors with a long-term, risk-tolerant outlook.
